Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical bills
A supreme court decision that overturned the “Chevron doctrine” could upend regulations on everything from tobacco to pharmaceuticals to surprise medical bills, experts told the Guardian.
The 40-year-old legal framework, the Chevron doctrine, once directed courts to defer to the expertise of federal agencies, such as the US Food and Drug Administration (FDA).
Continue reading…Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical billsA supreme court decision that overturned the “Chevron doctrine” could upend regulations on everything from tobacco to pharmaceuticals to surprise medical bills, experts told the Guardian.The 40-year-old legal framework, the Chevron doctrine, once directed courts to defer to the expertise of federal agencies, such as the US Food and Drug Administration (FDA). Continue reading…